BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
Author: Global Cancer Consortium
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
Imaging, Oncology, Drug Delivery. This company has developed an unprecedented technological platform to enable imaging at the smallest biological scale, the cell. The company’s technology utilizes combinatorial light and sound input to create accurate images of living cells and their inner structures, as well as to measure the electrical characteristics of the cell during intracellular structure interactions and activity. The company’s technology has wide ranging implications as cellular changes are a hallmark of disease, as is seen in the well characterized and consistently seen cellular changes present in cancerous tissue. Furthermore, the company’s technology consists of nanosensors that collect information…
Sword Diagnostics of Illinois has developed a “next-generation” system to increase the sensitivity (and therefore accuracy) of diagnostic tests.
LAMP (Lysosome-Associated Membrane Protein) is a gene that has been shown to enhance immune response when incorporated into a DNA vaccine.